-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Aurinia Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q2 2024.
- Aurinia Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2024 was -13.5 %, a 25.3% increase year-over-year.
- Aurinia Pharmaceuticals Inc. annual Return On Equity for 2023 was -20.1 %, a 21% increase from 2022.
- Aurinia Pharmaceuticals Inc. annual Return On Equity for 2022 was -25.4 %, a 48% increase from 2021.
- Aurinia Pharmaceuticals Inc. annual Return On Equity for 2021 was -48.9 %, a 61.3% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)